Biopharma Discovery Problems. Solved.
Learn how leading biopharmas and biotechs streamline their discovery workflows to innovate their biopharma research activities.
Meet Our CustomersOur Customers
Genedata Biologics® is widely used by big pharma as well as biotechs around the globe with collaborations that range from large enterprise-wide deployments to single group installations, and include technology transfer, customization, training, and rollout and deployment support.
MorphoSys Digitalizes
Large-Molecule R&D
Ten years ago, when MorphoSys was looking for a data management solution for their biologics R&D, they quickly realized that the small-molecule-based options available could not handle large-molecule discovery tasks. Then they met Genedata, whose enterprise platform is uniquely built for biotherapeutics. Genedata understood that biologics workflows, as well as protein sequence information, are completely different than the structural information for small molecules, and a lasting partnership was born.
Janssen, Celgene, and Aptevo Make Better Decisions
Genedata Biologics accelerates biotherapeutics R&D processes and provides a structured database with immediate and central access to all information along the discovery workflow. Janssen, Celgene, and Aptevo discuss how they use the platform to mine data, look at trends, and implement machine learning strategies to gain critical business intelligence so they can make better decisions.
Six Reasons Why Crescendo Biologics Uses Genedata
Crescendo Biologics is developing a novel class of small, robust protein therapeutics in the immuno-oncology and next-generation ADC space. Due to the complexity and scale of their product design activities and the vast amounts of data generated during candidate testing, they needed a scalable system to work as a backbone for all their R&D activities. Genedata Biologics supports their entire discovery process, spanning immunization of transgenic mice, lead selection, molecular modification, and final candidate assessments. The platform, referred to as their single source of truth, is crucial for their operations.
Meet the Genedata Community
The Genedata Biologics Partner Symposium is a unique interdisciplinary event at the interface between biopharma R&D and IT is your chance to learn how other companies have set up and are using Genedata platforms. Presentations and discussions will focus on innovative applications and new industry requirements, such as novel molecular formats (e.g., multispecifics, TCRs, and AAVs) and increasing automation and standardization in biopharmaceutical R&D. Leading biopharma companies will show how groups have set up, operate, and use Genedata platforms to transform their biotherapeutics research & development and how this results in increased efficiency and throughput.
Case Studies
Pfizer Builds on the Genedata E2E Workflow Platform
After conducting a thorough market evaluation to identify an off-the-shelf enterprise system for large-molecule discovery, Pfizer decided to implement Genedata Biologics as their central repository for their biologics discovery data, including screening, molecular biology, engineering, expression, purification, and analytics.
MorphoSys Accelerates Antibody R&D
After a formal selection process, MorphoSys decided to implement Genedata Biologics as their new enterprise workflow platform due to the fact that Genedata Biologics is the only turn-key system available in the antibody R&D space.
Selected Customer Presentations
Genedata's customers at leading biopharmaceutical and biotech companies worldwide regularly present how Genedata Biologics is used to advance their R&D activities. Learn how Pfizer, Bayer, UCB, Takeda, AbbVie, GSK, Kymab, Sanofi and others are streamlining processes and increasing the efficiency of their biotherapeutic discovery operations with the Genedata platform.
Our Customers Are Talking
First Commercial Data Management Solution
"Our collaboration with Genedata to develop a biologics data platform has been very successful. A commercial data management solution such as this has been sorely lacking in protein therapeutics."
Flexible Business Model Works for SMEs
"Thanks to Genedata’s flexible business model, we are able to take advantage of Genedata’s unique technology under terms that work well for a company of our size."
Central Registration & Data Management Platform
"Genedata seamlessly integrates into an existing research informatics environment and supports the full process through automation, standardization, and integration."
Flexible Architecture for Proprietary Configuration
“One of the reasons we chose Genedata Biologics was the platform’s process coverage. We required that the full diversity of Pfizer’s large-molecule processes and technologies be supported by one integrated system.”
Genedata Enables Data-Informed Decisions
“We are excited to implement the Genedata Biopharma Platform as a central integrated data backbone to streamline the capture, integration, democratization, and analysis of increasingly complex and diverse data types across Genmab’s discovery and clinical workflows."
No Customization Needed Due to Built-in Business Logic
“We chose Genedata Biologics because its built-in business logic avoids costly software customization and it’s a proven off-the-shelf-product that can be implemented quickly and replace our current processes.”
Esablished, Off-the-Shelf Product Deployed Quickly
“We appreciate Genedata Biologics’ flexible business model, which made it possible for a company of our size to adopt a market-leading platform solution.”
Genedata Accelerates Antibody Discovery at BI
"We undertook a thorough selection process to find the best antibody workflow platform and Genedata Biologics was the obvious choice."
Genedata Provides Backbone System
“Genedata Biologics was the clear choice as a backbone system to support the full diversity of our complex and rapidly evolving antibody discovery processes in the US and the UK.”
TCR Information Centrally Stored in Genedata
“Genedata Biologics gives all our R&D groups a central place to record and access TCR-related information in real time, along the end-to-end workflow."
Hard-to-Drug Targets Handled by Genedata
"The Genedata solution is now an integral part of our R&D infrastructure, supporting our efforts to develop novel biopharmaceuticals for hard-to-drug therapeutic targets.”
Orion Chooses Open & Scalable System
"Collaborating with CROs is a key part of our strategy, so we require an open and scalable system able to capture and integrate all data generated by our CRO network."
Mission-Critical Data Centrally Stored in Genedata
“We are rapidly expanding our biotherapeutic R&D activities and needed a scalable, flexible platform that we could quickly and easily implement. We chose Genedata Biologics as it is the only out-of-the-box platform on the market dedicated to large-molecule R&D.”
Scalable Backbone System Supports ADC Discovery
"Genedata Biologics is a key component of our growth plans in the immuno-oncology and next-generation ADC space. Thanks to its flexible architecture, Genedata Biologics can truly support our entire discovery process—right through from the immunization of transgenic mice, to lead selection, molecular modification and final candidate assessments.”
Immunotherapy Discovery Programs Scaled Up
“Genedata Biologics provides a flexible architecture and includes built-in biopharma domain knowledge, which can handle our proprietary bispecific antibody discovery processes. We believe Genedata Biologics will help us to accelerate the discovery of the next generation of immuno-oncology therapeutics.”
Streamlining Operations & Increasing Throughput
“We made a decision early on to use Genedata Biologics as MorphoSys’ workflow backbone to accelerate our drug discovery efforts and have watched as Genedata Biologics has become the global industry standard for biopharma discovery organizations."